Research programme: transcription factor modulators - vTv TherapeuticsAlternative Names: HPPE - vTv Therapeutics; Nrf2/Bach1 modulators - vTv Therapeutics
Latest Information Update: 05 Dec 2016
At a glance
- Originator vTv Therapeutics LLC
- Class Anti-inflammatories; Oxidoreductases; Small molecules
- Mechanism of Action NF-E2-related factor 2 modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Parkinson's disease